NSEGeneral Updates18h ago · 1 Sept 2026, 01:46 pm

General Updates

Sudarshan Chemical Industries Limited · SUDARSCHEM

✦ AI SummaryDivestiture

Sudarshan Chemical Industries Limited has informed the Exchange about the execution of a definitive Share Purchase and Transfer Agreement for the sale of 100% stake in VP4 Frankfurt GmbH, a Step-Down Wholly-Owned Subsidiary of the Company, to Celanese US Holdings LLC.

Analysis Scores

Earnings Impact6/10
Growth Catalyst4/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk8/10
Liquidity Impact9/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sudarshan Chemical Industries Limited has informed the Exchange about followingPursuant to the provisions of Regulation 30 of SEBI Listing Regulations, 2015 and in furtherance to our intimation and Press Release dated 1st September, 2026 regarding execution of definitive Share Purchase and Transfer Agreement for sale of 100% stake in VP4 Frankfurt GmbH, a Step-Down Wholly-Owned Subsidiary of the Company, we attach herewith a copy of the Investors Presentation, contents of which are self-explanatory.

Attachments (1)

📄

SUDARSCHEM_01092026134617_IRPresentation01092026Signed.pdf

pdf

Download →
View document text
1st September, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Mumbai – 400 001 Bandra Kurla Complex, Scrip Code – 506655 Bandra (East), Mumbai – 400 051 Scrip Symbol - SUDARSCHEM Dear Sir / Madam, Sub : Investors Presentation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (“SEBI Listing Regulations, 2015”) Pursuant to the provisions of Regulation 30 of SEBI Listing Regulations, 2015 and in furtherance to our intimation and Press Release dated 1st September, 2026 regarding execution of definitive Share Purchase and Transfer Agreement for sale of 100% stake in VP4 Frankfurt GmbH, a Step-Down Wholly-Owned Subsidiary of the Company, we attach herewith a copy of the Investors Presentation, contents of which are self-explanatory. The same is also being uploaded on the website of the Company at www.sudarshan.com Kindly take the same on record. Thanking You, Yours Faithfully, For SUDARSHAN CHEMICAL INDUSTRIES LIMITED MANDAR VELANKAR GENERAL COUNSEL AND COMPANY SECRETARY Encl.: As above. Sudarshan Chemical Industries Limited Registered Office: 7th Floor, Eleven West Panchshil, Survey No 25, Near PAN Card Club Road, Baner, Pune 411 069, Maharashtra, India T: +91 20 6828 1200 | www.sudarshan.com | shares@sudarshan.com | CIN: L24119PN1951PLC008409 Investor Presentation Sep 01, 2026 Intro to VP4 Frankfurt GmbH: Manufacturing facility for Diketene and CKP (Crotanaldehyde-Ketan- Polymer)  The VP4 facility primarily Arylides (Azo Used by Sudarshan serves Nutrinova’s food yellow pigment) additives business  Only a small proportion 90-95% of its production used by Sudarshan for captive Diketene & CKP Food additives Sold to Nutrinova consumption  Post closing, Nutrinova will supply required 2-3% quantity of Diketene to Sudarshan Other Sold to various other parties Introducing the buyer: Celanese US Holdings LLC All three parties were involved in the deal  Nutrinovais a joint venture between Celanese Corporation and Mitsui & Co  Nutrinovais the discoverer and producer of the acesulfame-K ("Sunett") sugar substitute  It also produces and sells the preservatives sorbic acid and potassium sorbate  Celanese will acquire and operate VP4 plant for a transitional period before ownership passes to Nutrinova Deal rationale: Moving VP4 Plant to the better strategic owner Divestment of step-down subsidiary VP4 Frankfurt GmbH ("VP4" Frankfurt) VP4 plant non-core for Sudarshan ... … but strategic for Nutrinova  VP4 Plant divestment strengthens our  Diketene & CKP are important intermediate strategic focus and operational position, for functional food ingredients (e.g., artificial sharpening our focus on core pigments sweetener acesulfame-K), making the asset business strong strategic fit with Nutrinova  Only 5% of the facility’s production used by us  JV-partner Mitsui required European-based as captive consumption – Post closing, diketene & CKP production – VP4 plant is one Nutrinova will supply required quantity of of the very few left actually in operations. Diketene to us.  This will benefit Mitsui with the upstream  The proceedings will strengthen our balance integration, spanning everything from RM sheet procurement to manufacture and sale of finished product. Details of deal Performance of VP4 Plant(EUR Mn): Sale of VP4 Frankfurt GmbH investment by Sudarshan Germany Horizons GmbH FY26 Q1FY27 Revenue 15.7 4.1 Post closing Diketene will be supplied by Nutrinova to Sudarshan, long term supply contract in place EBITDA 4.1 1.3 These proceeds will be primarily utilized for prepayment of acquisition loan Deal Value EUR 76.5 Mn This will further strengthen our balance sheet, and we will be zero net debt/positive cash company Expected closure in ~ 2-3 months Thank you